DRUG · Mapped RxNorm record
Pioglitazone
Normalized identity: pioglitazoneView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management
NCT02315287
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Lobeglitazone
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedComparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
PioglitazoneDRUG · verified · RxNorm: pioglitazone
LobeglitazoneDRUG
Sponsors & collaborators
Seoul National University Bundang Hospitallead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02315287 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.